Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Notch and T cell malignancy.

Patrick A Zweidler-McKay1, Warren S Pear

  • 1Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.

Seminars in Cancer Biology
|August 4, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NOTCH1 acts as a tumor suppressor that induces early differentiation in head and neck cancer.

JCI insight·2026
Same author

Preclinical characterization of the anti-leukemia activity of the CD123 antibody-drug conjugate, pivekimab sunirine (IMGN632).

Leukemia·2025
Same author

The CD123 antibody-drug conjugate pivekimab sunirine exerts profound activity in preclinical models of pediatric acute lymphoblastic leukemia.

HemaSphere·2025
Same author

MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231.

Blood·2024
Same author

Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody-drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study.

The Lancet. Oncology·2024
Same author

miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2.

JCI insight·2024
Same journal

Unveiling tumor heterogeneity by single cell RNA-sequencing: From basic considerations to clinical applications.

Seminars in cancer biology·2026
Same journal

Hidden architecture of resistance: The extracellular matrix in melanoma's immune landscape.

Seminars in cancer biology·2026
Same journal

Microfluidic technologies for extracellular vesicle isolation and analysis: Implications for translational applications in cancer therapy.

Seminars in cancer biology·2026
Same journal

Exploring glioblastoma microenvironment using organoids: opportunities, limitations, and emerging concepts.

Seminars in cancer biology·2026
Same journal

Special issue: Lipid metabolic alterations in cancer: Pathogenic mechanisms, therapies and common pathophysiology with cardiovascular disease.

Seminars in cancer biology·2026
Same journal

Systemic lipid metabolic alterations and the tumor microenvironment: A hidden driver of immune dysfunction.

Seminars in cancer biology·2026
See all related articles

Precise regulation of Notch signaling is crucial for T cell development. Aberrant Notch signaling can cause T cell lymphomas by interacting with key cellular pathways and cooperating with oncogenes.

Area of Science:

  • Immunology
  • Molecular Biology
  • Oncology

Background:

  • Notch signaling is essential for normal T cell development.
  • Dysregulated Notch signaling is implicated in T cell lymphomas.
  • Understanding Notch's role in lymphomagenesis is critical.

Purpose of the Study:

  • To review current knowledge on Notch-mediated T cell lymphomagenesis.
  • To explore the mechanisms linking Notch signaling to T cell development and cancer.
  • To highlight interactions between Notch and other cellular pathways in lymphomagenesis.

Main Methods:

  • Literature review of recent evidence.
  • Analysis of molecular mechanisms.
  • Examination of murine leukemia models.

Related Experiment Videos

Main Results:

  • Notch signaling interacts with critical cellular pathways.
  • Notch cooperates with oncogenes in lymphomagenesis.
  • Notch modulates pre-TCR signaling and inhibits the E2A pathway.

Conclusions:

  • Notch signaling dysregulation is a key factor in T cell lymphomas.
  • Notch cooperates with specific oncogenes like Myc in T cell cancers.
  • Further research into Notch-mediated lymphomagenesis is warranted.